Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study release_voyzb2wr2zfy5grg5rik42tmiq

by Adam Penn-Nicholson, Thomas Hraha, Ethan G. Thompson, David Sterling, Stanley Kimbung Mbandi, Kirsten M. Wall, Michelle Fisher, Sara Suliman, Smitha Shankar, Willem A. Hanekom, Nebojsa Janjic, Mark Hatherill (+7 others)


Both proteomic TB risk signatures predicted progression to incident TB within a year of diagnosis. To our knowledge, these are the first validated prognostic proteomic signatures. Neither meet the minimum criteria as defined in the WHO Target Product Profile for a progression test. More work is required to develop such a test for practical identification of individuals for investigation of incipient, subclinical, or active TB disease for appropriate treatment and care.
In text/plain format

Published in PLoS Medicine by Public Library of Science (PLoS)
ISSN-L 1549-1277
Volume 16
Issue 4
Page(s) e1002781
Release Date 2019-04-16
Container Type journal
Publisher Public Library of Science (PLoS)
Primary Language en (lookup)

Known Files and URLs

application/pdf  2.3 MB
sha1:5f76ced0c73b999a59fa... (webarchive) (web)
application/pdf  2.4 MB
sha1:b07e86ee4b2f5f67397d... (webarchive) (webarchive) (publisher)
Read Full Text
Type  article-journal
Stage   published
Date   2019-04-16
Container Metadata
Open Access Publication
ISSN-L:  1549-1277
Fatcat Entry
Work Entity
grouping other versions (eg, pre-print) and variants of this release
Cite This Release
Fatcat Bits

State is "active". Revision:
As JSON object via API